BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 27020037)

  • 1. Investigation of the clinical significance of the growth hormone-releasing peptide-2 test for the diagnosis of secondary adrenal failure.
    Arimura H; Hashiguchi H; Yamamoto K; Shinnakasu A; Arimura A; Kikuchi A; Deguchi T; Habu M; Fujio S; Arita K; Nishio Y
    Endocr J; 2016 Jun; 63(6):533-44. PubMed ID: 27020037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of pituitary-adrenal responsiveness between insulin tolerance test and growth hormone-releasing peptide-2 test: a pilot study.
    Kano T; Sugihara H; Sudo M; Nagao M; Harada T; Ishizaki A; Nakajima Y; Tanimura K; Okajima F; Tamura H; Ishii S; Shibasaki T; Oikawa S
    Peptides; 2010 Apr; 31(4):657-61. PubMed ID: 20045717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of adrenal function in patients with growth hormone deficiency and hypothalamic-pituitary disorders: comparison between insulin-induced hypoglycemia, low-dose ACTH, standard ACTH and CRH stimulation tests.
    Maghnie M; Uga E; Temporini F; Di Iorgi N; Secco A; Tinelli C; Papalia A; Casini MR; Loche S
    Eur J Endocrinol; 2005 May; 152(5):735-41. PubMed ID: 15879359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concordant and discordant adrenocorticotropin (ACTH) responses induced by growth hormone-releasing peptide-2 (GHRP-2), corticotropin-releasing hormone (CRH) and insulin-induced hypoglycemia in patients with hypothalamopituitary disorders: evidence for direct ACTH releasing activity of GHRP-2.
    Kimura T; Shimatsu A; Arimura H; Mori H; Tokitou A; Fukudome M; Nakazaki M; Tei C
    Endocr J; 2010; 57(7):639-44. PubMed ID: 20431231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic usefulness of the growth hormone-releasing peptide-2 test as a substitute for the insulin tolerance test in hypopituitarism.
    Kageyama K; Nigawara T; Sakihara S; Takayasu S; Terui K; Moriyama T; Suda T
    Endocr J; 2008 Aug; 55(4):777-83. PubMed ID: 18493103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of repetitive administration of corticotropin-releasing hormone combined with lysine vasopressin on plasma adrenocorticotropin and cortisol levels in secondary adrenocortical insufficiency.
    Fukata J; Usui T; Tsukada T; Nakai Y; Koh T; Ishihara T; Tanaka I; Uchida K; Yoshimasa T; Nakano R
    J Clin Endocrinol Metab; 1990 Dec; 71(6):1624-31. PubMed ID: 2172283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-acting intramuscular ACTH stimulation test for the diagnosis of secondary adrenal insufficiency in children.
    Sharma R; Madathil S; Maheshwari V; Roy K; Kumar B; Jain V
    J Pediatr Endocrinol Metab; 2019 Jan; 32(1):57-63. PubMed ID: 30530907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is the plasma ACTH concentration a reliable parameter in the insulin tolerance test?
    Borm K; Slawik M; Seiler L; Flohr F; Petrick M; Honegger J; Reincke M
    Eur J Endocrinol; 2003 Dec; 149(6):535-41. PubMed ID: 14640994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis of adrenal insufficiency using the GHRP-6 Test: comparison with the insulin tolerance test in patients with hypothalamic-pituitary-adrenal disease.
    Alaioubi B; Mann K; Petersenn S
    Horm Metab Res; 2010 Mar; 42(3):198-203. PubMed ID: 19946832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRH and lysine-vasopressin stimulation tests in the diagnosis of hypoadrenalism secondary to hypothalamic or pituitary disorders.
    Cantalamessa L; Catania A; Baldini M; Orsatti A; Motta P; Peracchi G
    Horm Metab Res; 1990 Jul; 22(7):389-93. PubMed ID: 2169450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cortisol cut-points for the glucagon stimulation test in the evaluation of hypothalamic pituitary adrenal axis.
    Ach T; Yosra H; Jihen M; Abdelkarim Asma B; Maha K; Molka C; Rouatbi S; Monia Z; Ach K
    Endocr J; 2018 Sep; 65(9):935-942. PubMed ID: 29952338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adrenocorticotropic hormone and cortisol response to corticotropin releasing hormone in the critically ill-a novel assessment of the hypothalamic-pituitary-adrenal axis.
    Schuster KM; Macleod JB; Fernandez JB; Kumar M; Barquist ES
    Am J Surg; 2012 Feb; 203(2):205-10. PubMed ID: 21679920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis of adrenal insufficiency: Evaluation of the corticotropin-releasing hormone test and Basal serum cortisol in comparison to the insulin tolerance test in patients with hypothalamic-pituitary-adrenal disease.
    Schmidt IL; Lahner H; Mann K; Petersenn S
    J Clin Endocrinol Metab; 2003 Sep; 88(9):4193-8. PubMed ID: 12970286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of the hypothalamo-pituitary-adrenal axis by the growth hormone (GH) secretagogue, GH-releasing peptide-6, in rats.
    Thomas GB; Fairhall KM; Robinson IC
    Endocrinology; 1997 Apr; 138(4):1585-91. PubMed ID: 9075719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison between the 1-microg adrenocorticotropin (ACTH) test, the short ACTH (250 microg) test, and the insulin tolerance test in the assessment of hypothalamo-pituitary-adrenal axis immediately after pituitary surgery.
    Dökmetaş HS; Colak R; Keleştimur F; Selçuklu A; Unlühizarci K; Bayram F
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3713-9. PubMed ID: 11061529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of secondary adrenal insufficiency: findings by corticotropin-releasing hormone test and magnetic resonance imaging in parallel.
    Lin SY; Won JG; Lee TI; Tang KT; Lin HD
    Zhonghua Yi Xue Za Zhi (Taipei); 2002 Apr; 65(4):156-63. PubMed ID: 12135194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma adrenocorticotropin and cortisol responses to ovine corticotropin-releasing factor in patients with adrenocortical insufficiency due to hypothalamic and pituitary disorders.
    Tsukada T; Nakai Y; Koh T; Tsujii S; Inada M; Nishikawa M; Shinoda H; Kawai I; Takezawa N; Imura H
    J Clin Endocrinol Metab; 1984 Apr; 58(4):758-60. PubMed ID: 6321536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of pulsatile human corticotropin-releasing hormone administration on the adrenal insufficiency that follows cure of Cushing's disease.
    Avgerinos PC; Nieman LK; Oldfield EH; Loughlin T; Barnes KM; Loriaux DL; Cutler GB
    J Clin Endocrinol Metab; 1989 May; 68(5):912-6. PubMed ID: 2541160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A simple diagnostic test using GH-releasing peptide-2 in adult GH deficiency.
    Chihara K; Shimatsu A; Hizuka N; Tanaka T; Seino Y; Katofor Y;
    Eur J Endocrinol; 2007 Jul; 157(1):19-27. PubMed ID: 17609397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Corticotropin releasing hormone: relevance to normal physiology and to the pathophysiology and differential diagnosis of hypercortisolism and adrenal insufficiency.
    Gold PW; Kling MA; Khan I; Calabrese JR; Kalogeras K; Post RM; Avgerinos PC; Loriaux DL; Chrousos GP
    Adv Biochem Psychopharmacol; 1987; 43():183-200. PubMed ID: 3035886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.